Evolv Technologies Holdings, Inc. $EVLV is Key Colony Management LLC’s 2nd Largest Position

Key Colony Management LLC grew its stake in Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) by 5.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,275,095 shares of the company’s stock after buying an additional 170,095 shares during the period. Evolv Technologies accounts for 33.5% of Key Colony Management LLC’s investment portfolio, making the stock its 2nd largest holding. Key Colony Management LLC owned about 1.91% of Evolv Technologies worth $24,727,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Evolv Technologies by 5.3% in the first quarter. Vanguard Group Inc. now owns 9,402,716 shares of the company’s stock valued at $29,336,000 after acquiring an additional 477,124 shares in the last quarter. Nuveen LLC purchased a new position in Evolv Technologies during the 1st quarter worth approximately $977,000. American Century Companies Inc. increased its position in Evolv Technologies by 6.1% during the first quarter. American Century Companies Inc. now owns 63,315 shares of the company’s stock worth $198,000 after buying an additional 3,633 shares during the period. CW Advisors LLC purchased a new stake in Evolv Technologies in the first quarter valued at approximately $33,000. Finally, MetLife Investment Management LLC lifted its stake in Evolv Technologies by 5.1% in the first quarter. MetLife Investment Management LLC now owns 91,042 shares of the company’s stock valued at $284,000 after buying an additional 4,412 shares during the last quarter. 66.65% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Anil Chitkara sold 120,000 shares of Evolv Technologies stock in a transaction that occurred on Monday, October 27th. The stock was sold at an average price of $8.20, for a total value of $984,000.00. Following the sale, the insider directly owned 1,275,100 shares in the company, valued at $10,455,820. The trade was a 8.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kevin M. Charlton acquired 15,000 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $5.68 per share, for a total transaction of $85,200.00. Following the acquisition, the director directly owned 44,081 shares of the company’s stock, valued at $250,380.08. This trade represents a 51.58% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders purchased 61,300 shares of company stock worth $363,326 and sold 440,745 shares worth $3,618,954. 11.30% of the stock is owned by corporate insiders.

Evolv Technologies Stock Performance

Shares of EVLV opened at $6.86 on Wednesday. The stock has a market capitalization of $1.20 billion, a P/E ratio of -18.54 and a beta of 1.85. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.20 and a current ratio of 1.27. Evolv Technologies Holdings, Inc. has a 1 year low of $2.64 and a 1 year high of $8.91. The company’s fifty day moving average is $7.09 and its two-hundred day moving average is $6.98.

Evolv Technologies (NASDAQ:EVLV) last issued its earnings results on Thursday, November 13th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.06. The business had revenue of $42.85 million for the quarter, compared to the consensus estimate of $33.73 million. Evolv Technologies had a negative net margin of 43.76% and a negative return on equity of 55.11%. On average, sell-side analysts predict that Evolv Technologies Holdings, Inc. will post -0.27 earnings per share for the current year.

Analyst Ratings Changes

EVLV has been the topic of a number of research reports. Zacks Research upgraded shares of Evolv Technologies from a “strong sell” rating to a “hold” rating in a research report on Friday, October 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of Evolv Technologies in a research report on Wednesday, October 8th. Finally, Lake Street Capital upped their target price on shares of Evolv Technologies from $9.00 to $10.00 and gave the company a “buy” rating in a report on Friday, November 14th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $9.13.

Evolv Technologies Company Profile

Evolv Technologies Holdings, Inc provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally. Its products include Evolv Express, a touchless security screening system designed to detect firearms, improvised explosive devices, and tactical knives; and Evolv Insights that provides self-serve access, insights regarding visitor flow and arrival curves, location specific performance, system detection performance, and alarm statistics.